Carissa James

Director of Research and Development at Xequel Bio - Fort Worth, Texas, United States

Carissa James's Colleagues at Xequel Bio
Jerry Peter

Chief Executive Officer & Board Director

Contact Jerry Peter

Meghan Bowler

Translational Scientist

Contact Meghan Bowler

Susanne Haugebak

Director Clinical Operations

Contact Susanne Haugebak

Linda Davis

Sr. Director, Administration & HR

Contact Linda Davis

View All Carissa James's Colleagues
Carissa James's Contact Details
HQ
+1 843-860-8372
Location
Charleston,South Carolina,United States
Company
Xequel Bio
Carissa James's Company Details
Xequel Bio logo, Xequel Bio contact details

Xequel Bio

Fort Worth, Texas, United States • 10 Employees
Research

Xequel Bio, Inc. is a clinical stage biopharmaceutical company advancing its proprietary aCT1 (alpha-Connexin carboxyl-Terminal 1 peptide) technology platform to develop drugs that will enable physicians to better manage a variety of indications involving inflammation and the body's response to injury.aCT1 is a patented new chemical entity currently in development for multiple indications. The Company's lead clinical programs include Granexin® gel in dermatology and iNexinTM ophthalmic solution in ophthalmology. The Company also has ongoing preclinical research in pulmonology.

Details about Xequel Bio
Frequently Asked Questions about Carissa James
Carissa James currently works for Xequel Bio.
Carissa James's role at Xequel Bio is Director of Research and Development.
Carissa James's email address is ***@firststringresearch.com. To view Carissa James's full email address, please signup to ConnectPlex.
Carissa James works in the Research industry.
Carissa James's colleagues at Xequel Bio are Jerry Peter, Meghan Bowler, Susanne Haugebak, Linda Davis, Irina Adamova, Kayla Wilson and others.
Carissa James's phone number is +1 843-860-8372
See more information about Carissa James